Arcadia Biosciences Receives Health Canada Approval For GoodHemp Varieties
GoodHemp seed varieties and genetics are distributed in Canada by Tritium 3H, Inc. (T3H), which specializes in hemp field testing, certified seed production, commercialization and distribution of industrial hemp varieties. The approval from Health Canada broadens the geographic opportunities for GoodHemp and enables growers to access high quality seeds through Tritium for the 2021 growing season.
“The Health Canada approval demonstrates the stability and compliance of our cultivars,” said Arcadia CEO Matt Plavan. “We are happy to report we have already shipped the first GoodHemp seed order to Tritium 3H to bring our CBD-dominant, short-day varieties to Canada’s industrial hemp growers for the 2021 planting season.”
GoodHemp varieties approved by Health Canada include:
- Umpqua: CBD-dominant, early photoperiod variety for both the smokable and CBD extraction markets. Prized for its unique terpene profile.
- Rogue: CBD-dominant, high-yielding intermediate photoperiod variety for the CBD extraction markets. Brings exceptional yields under low planting densities.
- Santiam: CBD-dominant, early photoperiod variety with exceptional utility in northern latitudes for both the smokable and CBD extraction markets. Delivers step change yield potential.
GoodHemp is Arcadia’s commercial portfolio of genetically superior hemp seeds, transplants and extracts introduced in 2019. Since then, Arcadia has been rapid-prototyping novel non-GM hemp varieties that target quality and performance characteristics highly desired by growers to overcome their greatest challenges. GoodHemp varieties have been field-tested extensively in regional and national trials by the T3H and Arcadia teams.
For more information about GoodHemp’s unique seed varieties, visit www.growgoodhemp.com.